Nephros (NEPH) Capital Expenditures (2010 - 2022)

Nephros (NEPH) posted quarterly Capital Expenditures of $103000.0 for Q2 2022, up 202.94% quarter-over-quarter from $34000.0 in Q1 2022.

Nephros (NEPH) Capital Expenditures (2010 - 2022) Analysis & Trends

Nephros' Capital Expenditures history runs 6 years deep, the most recent figure standing at $103000.0 for Q2 2022.

In Q2 2022, Capital Expenditures changed N/A year-over-year to $103000.0; the TTM figure through Sep 2024 stood at $103000.0 (changed N/A YoY), while the FY2024 annual figure was $55000.0, down 26.67% from the prior year.
Capital Expenditures for Q2 2022 stood at $103000.0, up from $34000.0 in the prior quarter.
The five-year high for Capital Expenditures was $103000.0 in Q2 2022, with the low at $13000.0 in Q3 2020.
The 3-year median for Capital Expenditures is $23000.0 (2021), against an average of $37200.0.
The sharpest annual moves came in 2021 and 2022: Capital Expenditures changed 0.0% in 2021, then jumped 47.83% in 2022.
Nephros' Capital Expenditures stood at $13000.0 in 2020, then changed by 0.0% to $13000.0 in 2021, then surged by 692.31% to $103000.0 in 2022.
Business Quant data shows NEPH's Capital Expenditures at $103000.0 in Q2 2022, $34000.0 in Q1 2022, and $13000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	112.60 Mn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	143.00 Mn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	374.00 Mn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	51.13 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	111.00 Mn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	43.20 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	83.00 Mn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	86.40 Mn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	116.00 Mn
10	Nephros	48.26 Mn	43.56 Mn	4.03 Mn	-

Download Data